White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk: A Perspective

Ann Intern Med. 2018 Mar 6;168(5):365-366. doi: 10.7326/M17-3340. Epub 2018 Jan 16.

Author

Alexander Dobrovic¹

Affiliation

¹ Olivia Newton-John Cancer Research Institute, Heidelberg, La Trobe University, Bundoora, and University of Melbourne, Parkville, Victoria, Australia (A.D.).

PMID: 29335711
DOI: 10.7326/M17-3340

No abstract available

Publication types

Editorial
Comment

MeSH terms

Female
Humans
Leukocytes
Methylation
Ovarian Neoplasms / genetics*
Promoter Regions, Genetic